4//SEC Filing
Klichinsky Michael 4
Accession 0001104659-24-072976
CIK 0001485003other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 7:06 PM ET
Size
5.8 KB
Accession
0001104659-24-072976
Insider Transaction Report
Form 4
Klichinsky Michael
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-06-17+85,000→ 85,000 totalExercise: $1.03Exp: 2034-06-17→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest over two years, with 50% of the shares vesting on June 17, 2025 and the remaining 50% of the shares vesting on June 17, 2026, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.
Documents
Issuer
Carisma Therapeutics Inc.
CIK 0001485003
Entity typeother
Related Parties
1- filerCIK 0001967221
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 7:06 PM ET
- Size
- 5.8 KB